Renaissance BioScience Corp. participating in Edison Open House: Global Healthcare 2022 Virtual Conference

 

Vancouver, Canada — January 26, 2022 — Renaissance BioScience Corp., a leading global bioengineering company, is pleased to announce that CEO Dr. John Husnik will be speaking at the Edison Open House: Global Healthcare 2022 virtual conference. The Open House consists of a number of leading-edge companies each being interviewed and providing information to online conference attendees. 

Renaissance is one of more than 30 companies being featured at the three-day event, which is being held in association with the London Stock Exchange, global law firm Taylor Wessing, and OpenExchange. Day one of the conference will feature businesses within pharmaceuticals and drug discovery, businesses adopting novel approaches to hard-to-solve problems, which includes Renaissance, will present on day two while AI and technology in healthcare will round off the third day of the event.

Content is now available to stream on Edison's website. Attendance is free and interested investors are encouraged to register for the event via the following link: https://www.edisongroup.com/event/edison-open-house-global-healthcare-2022/

Renaissance is presenting on day two of the conference. The company's session is available on demand on the conference website on Wednesday, January 26, 2022, and will subsequently be posted on the company's website. The Edison Group’s informational report on Renaissance BioScience can be viewed here: https://www.edisongroup.com/publication/rnai-technology-from-bioengineered-yeast-2/30419

About Renaissance BioScience Corp.

Based in Vancouver, Canada, Renaissance is an environmental impact company whose bioengineering platform technologies are used to develop innovative, market-ready, functional microorganisms that provide solutions to a broad range of health, environmental and industrial problems. Detailed information about the Renaissance group of companies is available at www.renaissancebioscience.com.

For further media information or to arrange interviews: 

Steve Campbell

Campbell & Company Strategies Inc.

Communications and Public Relations

Vancouver, BC, Canada

01 604 888-5267

renaissance@ccom-pr.com

For commercial or technology development inquiries:

Dr. John Husnik, CEO

Renaissance BioScience Corp.

Vancouver, BC, Canada

01 604 822-6499

jihusnik@renaissancebioscience.com

 

 

 

Back to all news